Advertisement

Pediatric Nephrology

, Volume 22, Issue 9, pp 1315–1320 | Cite as

Probiotics prophylaxis in children with persistent primary vesicoureteral reflux

  • Seung Joo LeeEmail author
  • Yoon Hee Shim
  • Su Jin Cho
  • Jung Won Lee
Original Article

Abstract

Probiotics, beneficial living microorganisms, have been proven to be effective in preventing gastrointestinal infections, but their effect in preventing urinary tract infection (UTI) is inconclusive. A prospective randomized controlled study was done to compare the preventive effect of probiotics with conventional antibiotics in children with persistent primary vesicoureteral reflux (VUR). One hundred twenty children who had had persistent primary VUR after antibiotic prophylaxis for 1 year were randomly allocated into a probiotics (Lactobacillus acidophilus 108 CFU/g 1 g b.i.d., n = 60) or an antibiotics (trimethoprim/sulfamethoxazole 2/10 mg/kg h.s., n = 60) prophylaxis group during the second year of follow-up. The incidence of recurrent UTI was 18.3% (11/60) in the probiotics group, which was not different from 21.6%(13/60) in the antibiotic group (P = 0.926). The causative organisms of recurrent UTI were not significantly different between the two groups (P = 0.938). Even after stratification by VUR grade, age, gender, phimosis, voiding dysfunction and renal scar, the incidence of recurrent UTI did not differ significantly between the two groups (P > 0.05). The development of new renal scar was not significantly different between the two groups (P > 0.05). In conclusion, probiotics prophylaxis was as effective as antibiotic prophylaxis in children with persistent primary VUR.

Keywords

Probiotics prophylaxis Lactobacillus acidophilus Recurrent UTI Antibiotic prophylaxis 

References

  1. 1.
    Elder JS, Peters CA, Arant BS Jr, Ewalt DH, Hawtery CE, Hasselblad V (1997) Pediatric vesicoureteral reflux guidelines panel summary report on the management of primary vesicoureteral reflux in children. J Urol 157:1846–1851PubMedCrossRefGoogle Scholar
  2. 2.
    Lettgen B (1996) Prevention of recurrent urinary tract infection in female children. Curr Ther Res 59:562–565Google Scholar
  3. 3.
    Williams G, Lee A, Craig J (2001) Antibiotics for the prevention of urinary tract infection in children: a systematic review of randomized controlled trials. J Pediatr 138:868–874PubMedCrossRefGoogle Scholar
  4. 4.
    William GJ, Lee A, Craig JC (2002) Longterm antibiotics for preventing recurrent urinary tract infection in children (Cochrane review) In the Cochrane library, Issue 3. Update software, OxfordGoogle Scholar
  5. 5.
    Ladhani S, Gransden W (2003) Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 88:444–445PubMedCrossRefGoogle Scholar
  6. 6.
    Evaluation of health and nutritional properties of probiotics in food including powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United States and World Health Organization Expert Consultation Report. Available at http://www.fao.org/es/ESN/Probio/probio.html2001.Cordoban, Argentina, 1–4 October 2001
  7. 7.
    Fuller R (1989) Probiotics in man and animals. J Appl Bacteriol 66:365–378PubMedGoogle Scholar
  8. 8.
    Falk PG, Hooper LV, Midtvedt T, Gordon JI (1998) Creating and maintaining the gastrointestinal ecosystem. What we know and need to know from gnotobiology. Microbiol Mol Biol Rev 62:1157–1170PubMedGoogle Scholar
  9. 9.
    Drisko J, Giles C, Bischoff B (2003) Probiotics in health maintenance and disease prevention. Altern Med Rev 8:143–155PubMedGoogle Scholar
  10. 10.
    Fedorak RN, Madsen K (2004) Probiotics and prebiotics in gastrointestinal disorders. Curr Opin Gastroenterol 20:146–155PubMedCrossRefGoogle Scholar
  11. 11.
    Bruce AW, Reid G (1988) Intravaginal instillation of lactobacilli for prevention of recurrent urinary tract infection. Can J Microbiol 34:49–52CrossRefGoogle Scholar
  12. 12.
    Reid G, Bruce AW, Taylor M (1995) Instillation of lactobacillus and stimulation of indigenous organisms to prevent recurrence of urinary tract infections. Microecol Ther 23:32–45Google Scholar
  13. 13.
    Cadieux P, Burton J, Gardiner G, Braunstein I, Bruce AW, Kang CY, Reid G (2002) Lactobacillus strains and vaginal ecology. JAMA 287:1940–1946PubMedCrossRefGoogle Scholar
  14. 14.
    Kontiokari T, Laitinen J, Jarvi L, Pokka T, Sundqvist K, Uhari M (2003) Dietary factors protecting women from urinary tract infection. Am J Clin Nutr 77:600–604PubMedGoogle Scholar
  15. 15.
    Reid G, Charbonneau D, Erb J, Kochanowski B, Beuerman D, Poehner R, Bruce AW (2003) Oral use of Lactobacillus rhamnosus GR-1 and L. fermentum RC-14 significantly alters vaginal flora: randomized, placebo-controlled trial in 64 healthy woman. FEMS Immunol Microbiol 35:131–134CrossRefGoogle Scholar
  16. 16.
    Gardiner GE, Heinemann C, Bruce AW, Beuerman D, Reid G (2002) Persistence of Lactobacillus fermentum RC-14 and Lactobacillus rhamnosus GR-1, but not L. rhamnosus GG in the human vagina as demonstrated by randomly amplified polymorphic DNA. Clin Diagn Lab Immunol 9:2002–2008CrossRefGoogle Scholar
  17. 17.
    Reid G, Bruce AW, Talyer M (1992) Influence of three day antimicrobial therapy and lactobacillus suppositories on recurrent urinary tract infection. Clin Ther 14:11–16PubMedGoogle Scholar
  18. 18.
    Reid G, Hammond JA, Bruce AW (2003) Effect of lactobacilli oral supplement on the vaginal microflora of antibiotic treated patients: randomized placebo controlled study. Nutraceut Food 8:145–148CrossRefGoogle Scholar
  19. 19.
    Marild S, Hansson S, Jodal U, Oden A, Svedberg K (2004) Protective effect of breastfeeding against urinary tract infection. Acta Paediatr 93:164–168PubMedCrossRefGoogle Scholar
  20. 20.
    Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF (2002) Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 82:103–108PubMedCrossRefGoogle Scholar
  21. 21.
    Gerasimov SV (2004) Probiotic prophylaxis in pediatric recurrent urinary tract infections. Clin Pediatr 43:95–98CrossRefGoogle Scholar
  22. 22.
    Lohr JA, Numley DH, Howards SS, Ford RF (1977) Prevention of recurrent urinary tract infection in girls. Pediatrics 59:562–565PubMedGoogle Scholar
  23. 23.
    Newman D (1915) The treatment of cystitis by intravesical injection of lactic bacillus cultures. Lancet 14:330–332CrossRefGoogle Scholar
  24. 24.
    Bruce AW, Chadwick P, Hassan A, VanCott GF (1973) Recurrent urethritis in women. Can Med Assoc J 108:973–976PubMedGoogle Scholar
  25. 25.
    Gupta K, Stapleton AE, Hooton TM, Roberts PL, Fennell CL, Stamm WE (1998) Inverse association of H2O2-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infection. J Infect Dis 178:446–450PubMedGoogle Scholar
  26. 26.
    Chan RCY, Bruce AW, Reid G (1984) Adherence of cervical, vaginal and distal urethral normal microbial flora to human uroepithelial cells and the inhibition of adherences of uropathogens by competitive exclusion. J Urol 131:596–601PubMedGoogle Scholar
  27. 27.
    Reid G, Cook RL, Bruce AW (1987) Examination of strains of lactobacilli for properties that may influence bacterial interference in the urinary tract. J Urol 138:330–335PubMedGoogle Scholar
  28. 28.
    Velraeds MC, van der Mei HC, Reid G, Busscher HJ (1996) Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactant from lactobacillus isolates. Appl Environ Microbiol 62:1958–1963PubMedGoogle Scholar
  29. 29.
    McGroarty JA, Reid G (1998) Detection of a lactobacillus substance which inhibits Escherichia coli. Can J Microbiol 34:974–978CrossRefGoogle Scholar
  30. 30.
    Shahani AKM, Vakil JR, Kilara A (1976) Natural antibiotic activity of Lactobacillus acidophilus and bulgaricus. I. Cultural condition for the production of antibiosis. Cultured Dairy Prod J 11:14–17Google Scholar
  31. 31.
    Osset J, Bartolome RM, Garcia E, Andreu A (2001) Assessment of the capacity of lactobacillus to inhibit the growth of uropathogens and block their adhesion to vagina epithelial cells. J Infect Dis 183:485–491PubMedCrossRefGoogle Scholar
  32. 32.
    Saunders ME, Klaenhammer TR (2001) Invited review: The scientific basis of Lactobacillus acidophilus NCFM functionality as a probiotic. J Dairy Sci 84:319–331CrossRefGoogle Scholar
  33. 33.
    Reid G, Chan RCY, Bruce AW, Costerton JW (1985) Prevention of urinary tract infection in rats with an indigenous lactobacillus casei strain. Infect Immun 49:320–324PubMedGoogle Scholar
  34. 34.
    Asahara T, Nomoto K, Watanuki M, Yokokura T (2001) Antimicrobial activity of intraurethrally administered probiotic Lactobacilli casei in a murine model of Escherichia coli urinary tract infection. Antimicrob Agents Chemother 45:1751–1760PubMedCrossRefGoogle Scholar
  35. 35.
    Reid G, Bruce AW (2006) Probiotics to prevent urinary tract infections: the rationale and evidence. World J Urol 24:28–32PubMedCrossRefGoogle Scholar
  36. 36.
    Reid G (2005) The importance of guidelines in the development and application of probiotics. Curr Pharm Des 11:11–16PubMedCrossRefGoogle Scholar

Copyright information

© IPNA 2007

Authors and Affiliations

  • Seung Joo Lee
    • 1
    Email author
  • Yoon Hee Shim
    • 1
  • Su Jin Cho
    • 1
  • Jung Won Lee
    • 2
  1. 1.Department of PediatricsEwha Womans University College of Medicine, Ewha Medical Research CenterSeoulSouth Korea
  2. 2.Hallym University College of MedicineSeoulSouth Korea

Personalised recommendations